• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

山东省1993 - 1996年临床脊髓灰质炎分析

[Analysis of clincal poliomyelitis in Shandong Province from 1993-1996].

作者信息

Lei J, Li L, Xu A

机构信息

Shandong Provincial Epidemic Prevention Center, Jinan.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 1998 Dec;19(6):327-9.

PMID:10921114
Abstract

Wild poliovirus has not been isolated in Shandong province since Apr. 1991. However, 71 clinically polio cases were diagnosed by an expert group, including 50 potential Vaccine Associated Paralytic Poliomyelitis (VAPP) including 31 having the sabin strain in the stools, from 1993 to 1996. The overall frequency of VAPP was one case per 1.25 million doses distributed. The relative frequencies of first dose in the OPV series was one case per 218,800 doses vs one case per 1.01 million for second dose. Based on data from the 31 cases, we estimated that the rates had been one case per 438,000 first dose and one case per 6.42 million second dose and one case per 10.44 million among the contacts of the cases. This results seemed to be higher than from other reports. Clinically confirmed poliomyelitis cases in Shandong were diagnosed by the experts group. The classification of clinical polio cases is important in the polio eradication program.

摘要

自1991年4月以来,山东省未分离出野生脊髓灰质炎病毒。然而,1993年至1996年,一个专家组诊断出71例临床脊髓灰质炎病例,其中包括50例潜在的疫苗相关麻痹性脊髓灰质炎(VAPP),其中31例粪便中有萨宾株。VAPP的总体发生率为每分发125万剂出现1例。口服脊髓灰质炎疫苗(OPV)系列中首剂的相对发生率为每218,800剂出现1例,而第二剂为每101万剂出现1例。根据31例病例的数据,我们估计首剂发生率为每43.8万剂出现1例,第二剂为每642万剂出现1例,病例接触者中为每1044万剂出现1例。这一结果似乎高于其他报告。山东省临床确诊的脊髓灰质炎病例由专家组诊断。临床脊髓灰质炎病例的分类在脊髓灰质炎根除计划中很重要。

相似文献

1
[Analysis of clincal poliomyelitis in Shandong Province from 1993-1996].山东省1993 - 1996年临床脊髓灰质炎分析
Zhonghua Liu Xing Bing Xue Za Zhi. 1998 Dec;19(6):327-9.
2
Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.白俄罗斯的疫苗相关麻痹性脊髓灰质炎及其他伴有急性弛缓性麻痹综合征的疾病
Cent Eur J Public Health. 2003 Dec;11(4):213-8.
3
Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.匈牙利与萨宾单价和双价口服脊髓灰质炎疫苗相关的麻痹性脊髓灰质炎。
Am J Epidemiol. 2011 Aug 1;174(3):316-25. doi: 10.1093/aje/kwr070. Epub 2011 Jun 17.
4
Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.1999年印度的疫苗相关麻痹型脊髓灰质炎:尽管大量使用口服脊髓灰质炎疫苗,但风险降低
Bull World Health Organ. 2002;80(3):210-6.
5
Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.1989 - 1991年拉丁美洲疫苗相关麻痹性脊髓灰质炎的风险
Bull World Health Organ. 1995;73(1):33-40.
6
Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.对从伊朗疫苗相关麻痹型脊髓灰质炎病例中分离出的1型脊髓灰质炎病毒萨宾株VP(1)区域突变的特征分析。
J Clin Virol. 2007 Aug;39(4):304-7. doi: 10.1016/j.jcv.2007.04.017. Epub 2007 Jun 21.
7
Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000.1971年至2000年间日本疫苗相关麻痹性脊髓灰质炎风险的泊松模型分析。
Jpn J Infect Dis. 2008 Mar;61(2):100-3.
8
[Poliomyelitis surveillance in Shandong Province from 1991-1994].山东省1991 - 1994年脊髓灰质炎监测
Zhonghua Liu Xing Bing Xue Za Zhi. 1995 Dec;16(6):354-8.
9
[VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].[俄罗斯联邦在疫苗接种计划变更期间(2006 - 2013年)的疫苗相关麻痹性脊髓灰质炎]
Vopr Virusol. 2016;61(1):9-15.
10
The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.在全球根除脊髓灰质炎行动战略计划框架内,罗马尼亚对急性弛缓性麻痹(AFP)病例开展基于实验室的主动监测。
Roum Arch Microbiol Immunol. 2007 Jan-Jun;66(1-2):44-50.